Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2022 Q1- Text added to 2022 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Avg
|
New words:
approach, Chief, Council, discretion, good, Harmonization, moved, practice, proportional, proposal, recommendation, renewed, reverse, split, stockholder, Technical
Removed:
activity, advisory, atopic, breast, carcinoma, cell, colorectal, entered, equivalent, Ewing, FDA, Food, gastrointestinal, GI, granted, HCC, head, hepatocellular, led, leukemia, liver, lung, mCRC, melanoma, metastatic, mNET, mUM, murine, neck, neuroblastoma, neuroendocrine, ocular, ODD, Orphan, osteosarcoma, reportedly, rhabdomyosarcoma, sarcoma, testicular, transformation, uveal
Valuein 2022 Q1 filing- Value in 2022 Q2 filing
Original filings
Filing view